Stanowska, O.; Kuczkiewicz-Siemion, O.; Dębowska, M.; Olszewski, W.P.; Jagiełło-Gruszfeld, A.; Tysarowski, A.; Prochorec-Sobieszek, M.
PD-L1-Positive High-Grade Triple-Negative Breast Cancer Patients Respond Better to Standard Neoadjuvant Treatment—A Retrospective Study of PD-L1 Expression in Relation to Different Clinicopathological Parameters. J. Clin. Med. 2022, 11, 5524.
https://doi.org/10.3390/jcm11195524
AMA Style
Stanowska O, Kuczkiewicz-Siemion O, Dębowska M, Olszewski WP, Jagiełło-Gruszfeld A, Tysarowski A, Prochorec-Sobieszek M.
PD-L1-Positive High-Grade Triple-Negative Breast Cancer Patients Respond Better to Standard Neoadjuvant Treatment—A Retrospective Study of PD-L1 Expression in Relation to Different Clinicopathological Parameters. Journal of Clinical Medicine. 2022; 11(19):5524.
https://doi.org/10.3390/jcm11195524
Chicago/Turabian Style
Stanowska, Olga, Olga Kuczkiewicz-Siemion, Małgorzata Dębowska, Wojciech P. Olszewski, Agnieszka Jagiełło-Gruszfeld, Andrzej Tysarowski, and Monika Prochorec-Sobieszek.
2022. "PD-L1-Positive High-Grade Triple-Negative Breast Cancer Patients Respond Better to Standard Neoadjuvant Treatment—A Retrospective Study of PD-L1 Expression in Relation to Different Clinicopathological Parameters" Journal of Clinical Medicine 11, no. 19: 5524.
https://doi.org/10.3390/jcm11195524
APA Style
Stanowska, O., Kuczkiewicz-Siemion, O., Dębowska, M., Olszewski, W. P., Jagiełło-Gruszfeld, A., Tysarowski, A., & Prochorec-Sobieszek, M.
(2022). PD-L1-Positive High-Grade Triple-Negative Breast Cancer Patients Respond Better to Standard Neoadjuvant Treatment—A Retrospective Study of PD-L1 Expression in Relation to Different Clinicopathological Parameters. Journal of Clinical Medicine, 11(19), 5524.
https://doi.org/10.3390/jcm11195524
